White Anne E. 4
4 · ELI LILLY & Co · Filed Feb 14, 2023
Insider Transaction Report
Form 4
White Anne E.
EVP & Pres, Lilly Neuroscience
Transactions
- Award
Common Stock
2023-02-10$345.12/sh+8,562$2,954,917→ 62,926 total - Sale
Common Stock
2023-02-10$342.76/sh−2,500$856,900→ 60,426 total - Sale
Common Stock
2023-02-13$346.47/sh−2,500$866,175→ 57,926 total - Award
Restricted Stock Unit
2023-02-10+4,124→ 4,124 totalFrom: 2024-02-01Exp: 2024-02-01→ Common Stock (4,124 underlying)
Footnotes (2)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 2, 2022.
- [F2]Each restricted stock unit represents a contingent right to receive one share of Eli Lilly and Company common stock.